File Download

There are no files associated with this item.

Supplementary

Conference Paper: Phase II open label study of single agent sorafenib in treating advanced hepatocellular carcinoma in hepatitis-B endemic Asian population: presence of lung metastasis predicts poor response

TitlePhase II open label study of single agent sorafenib in treating advanced hepatocellular carcinoma in hepatitis-B endemic Asian population: presence of lung metastasis predicts poor response
Authors
Yau, TCC
Issue Date2008
Citation
6th International Meeting Hepatocellular Carcinoma: Eastern and Western Experiences (IMHCC 2008), Soeul, Korea, 7-9 December 2008 How to Cite?
Descriptionhttp://www.med.kobe-u.ac.jp/hbps/kenkyuu/gakkai_2008.html
Persistent Identifierhttp://hdl.handle.net/10722/239203

 

DC FieldValueLanguage
dc.contributor.authorYau, TCC-
dc.date.accessioned2017-03-10T07:56:17Z-
dc.date.available2017-03-10T07:56:17Z-
dc.date.issued2008-
dc.identifier.citation6th International Meeting Hepatocellular Carcinoma: Eastern and Western Experiences (IMHCC 2008), Soeul, Korea, 7-9 December 2008-
dc.identifier.urihttp://hdl.handle.net/10722/239203-
dc.descriptionhttp://www.med.kobe-u.ac.jp/hbps/kenkyuu/gakkai_2008.html-
dc.languageeng-
dc.relation.ispartofInternational Meeting Hepatocellular Carcinoma (IMHCC)-
dc.titlePhase II open label study of single agent sorafenib in treating advanced hepatocellular carcinoma in hepatitis-B endemic Asian population: presence of lung metastasis predicts poor response-
dc.typeConference_Paper-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.identifier.hkuros216971-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats